See All Slides - tctmd.com

Slides

Presentation

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

Presenter: M. Leoncini

October 09, 2013

Presentation

Short-term Rosuvastatin for Prevention of Contrast-Induced Acute Kidney Injury (CI-AKI) in Patients with Diabetes and Chronic Kidney Disease

Presenter: Yaling Han

October 09, 2013

Presentation

Presentation, Treatment, and Outcome Differences Between Men and Women Undergoing Revascularization or Amputation for Lower Extremity PAD

Presenter: R.C. Lo

October 08, 2013

Presentation

Risk of MACE Following Noncardiac Surgery in Patients with Coronary Stents

Presenter: Mary T. Hawn

October 08, 2013

Presentation

Interplay Between Mitral Regurgitation and TAVR with CoreValve

Presenter: F. Bedogni

October 07, 2013

Presentation

Trends in the Outcomes of PCI with the Routine Incorporation of FFR in Real Practice

Presenter: Seung-Jung Park

October 07, 2013

Presentation Scripps 2013

Patient Selection for Direct Thrombin Inhibitors during PCI

Presenter: Steven P. Marso

October 04, 2013

Presentation Scripps 2013

PFO, PDA, VSD, Paravalvular Leak: Should All the Holes Be Closed?

Presenter: Matthew J. Price

October 04, 2013

Presentation Scripps 2013

Acute MI Update 2013

Presenter: Barry D. Rutherford

October 04, 2013

Presentation Scripps 2013

Complex 3 Vessel Disease and Unprotected Left Main PCI: What Is the Role of Stents in the Post

Presenter: Paul S. Teirstein

October 04, 2013

Advertisement

Slides

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

Short-term Rosuvastatin for Prevention of Contrast-Induced Acute Kidney Injury (CI-AKI) in Patients with Diabetes and Chronic Kidney Disease

Presentation, Treatment, and Outcome Differences Between Men and Women Undergoing Revascularization or Amputation for Lower Extremity PAD

Risk of MACE Following Noncardiac Surgery in Patients with Coronary Stents

Interplay Between Mitral Regurgitation and TAVR with CoreValve

Trends in the Outcomes of PCI with the Routine Incorporation of FFR in Real Practice

Patient Selection for Direct Thrombin Inhibitors during PCI

PFO, PDA, VSD, Paravalvular Leak: Should All the Holes Be Closed?

Acute MI Update 2013

Complex 3 Vessel Disease and Unprotected Left Main PCI: What Is the Role of Stents in the Post

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content